This report, titled "No Time for Silence: Exploring Policy Approaches to Investment in Stroke Prevention in Europe," is an independent study sponsored by The Bristol Myers Squibb-Pfizer Alliance. The research focuses on policy and investment efforts to prevent stroke, including resources for education, awareness, and detection. The study was conducted in five major European countries: France, Germany, Italy, Spain, and the UK. The findings are based on a survey of over 250 senior executives in patient advocacy groups, the healthcare workforce, and healthcare policymakers and payers. The report's main findings are that prevention is Europe's greatest stroke priority, and that there is a need to align prevention priorities with investment priorities. The report also suggests boosting stroke awareness campaigns for early action and identifying who should play the biggest role in stroke prevention. The conclusion calls for instilling better practices for prevention.
